Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Irritable Bowel Syndrome, April 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 104 articles:
HTML format


 

Single Articles

  1. PATEL S, Tohme N, Gorrin E, Kumar N, et al
    Prevalence and risk factors for chalazion in an older veteran population.
    Br J Ophthalmol. 2021 Mar 31. pii: bjophthalmol-2020-318420.
    PubMed    
    Abstract available

  2. CHEN L, Xu WL, Pei LX, Wu XL, et al
    [Effect of Tiaoshen Jianpi acupuncture therapy on gut microbiota and fecal short-chain fatty acids in patients with diarrhea type irritable bowel syndrome].
    Zhongguo Zhen Jiu. 2021;41:137-41.
    PubMed    
    Abstract available

  3. XUAN YC, Liu J, Huang YY, Lu XY, et al
    [Therapeutic effect of long-snake moxibustion combined with western medication on diarrhea type irritable bowel syndrome of spleen and kidney yang deficiency].
    Zhongguo Zhen Jiu. 2021;41:133-6.
    PubMed    
    Abstract available

  4. COLOMBO JM, Deacy AD, Schurman JV, Friesen CA, et al
    Heartburn in children and adolescents in the presence of functional dyspepsia and/or irritable bowel syndrome correlates with the presence of sleep disturbances, anxiety, and depression.
    Medicine (Baltimore). 2021;100:e25426.
    PubMed    
    Abstract available

  5. YU K, Bunya V, Maguire M, Asbell P, et al
    Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study.
    Ophthalmology. 2021 Mar 27. pii: S0161-6420(21)00235.
    PubMed    
    Abstract available

  6. YAGIHASHI M, Kano M, Muratsubaki T, Morishita J, et al
    Concordant Pattern of the HPA Axis Response to Visceral Stimulation and CRH Administration.
    Neurosci Res. 2021 Mar 27. pii: S0168-0102(21)00067.
    PubMed    
    Abstract available

  7. MUNTJEWERFF EM, Tang K, Lutter L, Christoffersson G, et al
    Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides.
    Acta Physiol (Oxf). 2021 Mar 30:e13655. doi: 10.1111/apha.13655.
    PubMed    
    Abstract available

  8. BARBONE G, Jochum C
    [Functional Exams in the gastroenterology - new developments and tips for the common practice].
    Dtsch Med Wochenschr. 2021;146:441-445.
    PubMed    
    Abstract available

  9. TANG SQ, Wang YL, Xie ZY, Zhang Y, et al
    Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome.
    J Integr Med. 2021 Mar 16. pii: S2095-4964(21)00030.
    PubMed    
    Abstract available

  10. FORSGREN E, Bjorkman I
    Interactional practices in person-centred care: Conversation analysis of nurse-patient disagreement during self-management support.
    Health Expect. 2021 Mar 28. doi: 10.1111/hex.13236.
    PubMed    
    Abstract available

  11. ISHIOH M, Nozu T, Igarashi S, Tanabe H, et al
    Activation of central adenosine A2B receptors mediate brain ghrelin-induced improvement of intestinal barrier function through the vagus nerve in rats.
    Exp Neurol. 2021;341:113708.
    PubMed    
    Abstract available

  12. TAP J, Storsrud S, Le Neve B, Cotillard A, et al
    Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome.
    Microbiome. 2021;9:74.
    PubMed    
    Abstract available

  13. SASEGBON A, Vasant DH
    Understanding racial disparities in the care of patients with irritable bowel syndrome: The need for a unified approach.
    Neurogastroenterol Motil. 2021 Apr 9:e14152. doi: 10.1111/nmo.14152.
    PubMed    
    Abstract available

  14. OLIVER L, Ramio-Pujol S, Amoedo J, Malagon M, et al
    A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples.
    Front Microbiol. 2021;12:639948.
    PubMed    
    Abstract available

  15. ZYOUD SH, Smale S, Waring WS, Sweileh W, et al
    Global research trends in the microbiome related to irritable bowel syndrome: A bibliometric and visualized study.
    World J Gastroenterol. 2021;27:1341-1353.
    PubMed    
    Abstract available

  16. VEERARAGHAVAN G, Therrien A, Degroote M, McKeown A, et al
    Non-responsive celiac disease in children on a gluten free diet.
    World J Gastroenterol. 2021;27:1311-1320.
    PubMed    
    Abstract available

  17. RODRIGUES CS, Armendaris PM, de Sa CVGC, Haddad JPA, et al
    Prevalence of Campylobacter spp. in Chicken Carcasses in Slaughterhouses from South of Brazil.
    Curr Microbiol. 2021 Apr 8. pii: 10.1007/s00284-021-02478.
    PubMed    
    Abstract available

  18. GUINGAND DE RIVERY M, Zeinab H, Cohen V, Baumstarck K, et al
    Does faecal calprotectin increase may be linked to lactose intolerance in patients with irritable bowel syndrome?
    Minerva Gastroenterol (Torino). 2021 Apr 8. pii: S2724-5985.21.02802.
    PubMed    
    Abstract available

  19. QI LY, Wang Y, Wang LQ, She YF, et al
    Acupuncture for the treatment of diarrheal-predominant irritable bowel syndrome: study protocol for a pilot randomized controlled trial.
    Trials. 2021;22:253.
    PubMed    
    Abstract available

  20. ASLAM H, Mohebbi M, Ruusunen A, Dawson SL, et al
    Associations between dairy consumption and constipation in adults: A cross-sectional study.
    Nutr Health. 2021 Apr 8:2601060211004784. doi: 10.1177/02601060211004784.
    PubMed    
    Abstract available

  21. LAIRD KT, Stanton AL
    Written expressive disclosure in adults with irritable bowel syndrome: A randomized controlled trial.
    Complement Ther Clin Pract. 2021;43:101374.
    PubMed    
    Abstract available

  22. ALNOMAN A, Badeghiesh AM, Baghlaf HA, Dahan MH, et al
    Pregnancy, delivery, and neonatal outcomes among women with irritable bowel syndrome (IBS) an evaluation of over 9 million deliveries.
    J Matern Fetal Neonatal Med. 2021 Apr 6:1-8. doi: 10.1080/14767058.2021.1903421.
    PubMed    
    Abstract available

  23. TURKIEWICZ J, Bhatt RR, Wang H, Vora P, et al
    Altered brain structural connectivity in patients with longstanding gut inflammation is correlated with psychological symptoms and disease duration.
    Neuroimage Clin. 2021;30:102613.
    PubMed    
    Abstract available

  24. SUN Q, Liu Z, Zhang L, Wei H, et al
    Sex-Based Differences in Fecal Short-Chain Fatty Acid and Gut Microbiota in Irritable Bowel Syndrome Patients.
    J Dig Dis. 2021 Apr 6. doi: 10.1111/1751-2980.12988.
    PubMed    
    Abstract available

  25. DUNLAP LJ, Jaccard J, Lackner JM
    Minimal-Contact Versus Standard Cognitive Behavioral Therapy for with Irritable Bowel Syndrome: Cost-Effectiveness Results of a Multisite Trial.
    Ann Behav Med. 2021 Apr 3. pii: 6209755. doi: 10.1093.
    PubMed    
    Abstract available

  26. BEINVOGL B, Palmer N, Kohane I, Nurko S, et al
    Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population.
    Neurogastroenterol Motil. 2021 Apr 5:e14147. doi: 10.1111/nmo.14147.
    PubMed    
    Abstract available

  27. BENARDOUT M, Le Gresley A, ElShaer A, Wren SP, et al
    Fructose malabsorption: Causes, diagnosis and treatment.
    Br J Nutr. 2021 Apr 5:1-19. doi: 10.1017/S0007114521001215.
    PubMed    
    Abstract available

  28. SHEIKHESMAILI F, Jalili A, Taghizadeh E, Fakhari S, et al
    The CCL28 levels are elevated in the serum of patients with irritable bowel syndrome and associated with the clinical symptoms.
    Am J Clin Exp Immunol. 2021;10:23-29.
    PubMed    
    Abstract available

  29. HUANG ST, Song ZJ, Liu Y, Luo WC, et al
    BNSTAV (GABA)-PVN(CRF) Circuit Regulates Visceral Hypersensitivity Induced by Maternal Separation in Vgat-Cre Mice.
    Front Pharmacol. 2021;12:615202.
    PubMed    
    Abstract available

  30. SNISAREVSKYI PP
    MODERN MORPHOLOGICAL DIAGNOSTICS OF ULCERATIVE COLITIS AND IRRITABLE BOWEL SYNDROME: HISTOLOGICAL, HISTOCHEMICAL AND IMMUNOHISTOCHEMICAL CRITERIA.
    Wiad Lek. 2021;74.
    PubMed    
    Abstract available

  31. YDE J, Keely SJ, Moeller HB
    Expression, regulation and function of Aquaporin-3 in colonic epithelial cells.
    Biochim Biophys Acta Biomembr. 2021 Mar 31:183619.
    PubMed    
    Abstract available

  32. HARAN JP, Pinero JC, Zheng Y, Palma NA, et al
    Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physi
    Trials. 2021;22:245.
    PubMed    
    Abstract available

  33. PLAYFORD RJ, Choudhry N, Kelly P, Marchbank T, et al
    Effects of Bovine Colostrum with or without Egg on In Vitro Bacterial-Induced Intestinal Damage with Relevance for SIBO and Infectious Diarrhea.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  34. GIGANTE I, Tutino V, Russo F, De Nunzio V, et al
    Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  35. CASTRO-ALVAREZ A, Chavez-Angel E, Nelson R
    Understanding the Molecular Basis of 5-HT4 Receptor Partial Agonists through 3D-QSAR Studies.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  36. HEIDELBAUGH J, Martinez de Andino N, Pineles D, Poppers DM, et al
    Diagnosing Constipation Spectrum Disorders in a Primary Care Setting.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  37. CAPUTO F, Lungaro L, Galdi A, Zoli E, et al
    Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  38. FARUP PG, Maseng MG
    Are Faecal Microbiota Analyses on Species-Level Suitable Clinical Biomarkers? A Pilot Study in Subjects with Morbid Obesity.
    Microorganisms. 2021;9.
    PubMed    
    Abstract available

  39. HAGAN M, Hayee BH, Rodriguez-Mateos A
    (Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  40. DZIRLO L, Richter F, Steinmair D, Loffler-Stastka H, et al
    Reflective Functioning in Patients with Irritable Bowel Syndrome, Non-Affective Psychosis and Affective Disorders-Differences and Similarities.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  41. LINSALATA M, Riezzo G, Orlando A, D'Attoma B, et al
    The Relationship between Low Serum Vitamin D Levels and Altered Intestinal Barrier Function in Patients with IBS Diarrhoea Undergoing a Long-Term Low-FODMAP Diet: Novel Observations from a Clinical Trial.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  42. DUNCANSON K, Burns G, Pryor J, Keely S, et al
    Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  43. CHIMIENTI G, Orlando A, Lezza AMS, D'Attoma B, et al
    The Ketogenic Diet Reduces the Harmful Effects of Stress on Gut Mitochondrial Biogenesis in a Rat Model of Irritable Bowel Syndrome.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  44. RYAN JJ, Monteagudo-Mera A, Contractor N, Gibson GR, et al
    Impact of 2'-Fucosyllactose on Gut Microbiota Composition in Adults with Chronic Gastrointestinal Conditions: Batch Culture Fermentation Model and Pilot Clinical Trial Findings.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  45. MEIRA DE-FARIA F, Casado-Bedmar M, Marten Lindqvist C, Jones MP, et al
    Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome.
    Neurogastroenterol Motil. 2021 Apr 2:e14130. doi: 10.1111/nmo.14130.
    PubMed    
    Abstract available

  46. ALMARIO CV, Eberlein S, Khalil C, Spiegel BMR, et al
    Determining patient treatment preferences for management of acute pain episodes in irritable bowel syndrome.
    Neurogastroenterol Motil. 2021 Apr 2:e14145. doi: 10.1111/nmo.14145.
    PubMed    
    Abstract available

  47. JALANKA J, Lam C, Bennett A, Hartikainen A, et al
    Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine.
    J Neurogastroenterol Motil. 2021;27:279-291.
    PubMed    
    Abstract available

  48. LI J, He P, Lu X, Guo Y, et al
    A Resting-state Functional Magnetic Resonance Imaging Study of Whole-brain Functional Connectivity of Voxel Levels in Patients With Irritable Bowel Syndrome With Depressive Symptoms.
    J Neurogastroenterol Motil. 2021;27:248-256.
    PubMed    
    Abstract available

  49. LEE SW, Chang CS
    Impact of Overlapping Functional Gastrointestinal Disorders on the Quality of Life in Patients With Gastroesophageal Reflux Disease.
    J Neurogastroenterol Motil. 2021;27:176-184.
    PubMed    
    Abstract available

  50. WANG C, Fang X
    Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia.
    J Neurogastroenterol Motil. 2021;27:153-164.
    PubMed    
    Abstract available

  51. MUDRYJ A, Waugh A, Slater J, Duerksen DR, et al
    Dietary gluten avoidance in Canada: a cross-sectional study using survey data.
    CMAJ Open. 2021;9:E317-E323.
    PubMed    
    Abstract available

  52. PALSSON OS, Ballou S
    Hypnosis and Cognitive Behavioral Therapies for the Management of Gastrointestinal Disorders.
    Curr Gastroenterol Rep. 2020;22:31.
    PubMed    
    Abstract available

  53. YU X, Li Y, Xiang F, Feng J, et al
    Correlation between small intestinal bacterial overgrowth and irritable bowel syndrome and the prognosis of treatment.
    Ann Palliat Med. 2021;10:3364-3370.
    PubMed    
    Abstract available

  54. CAI T, Wang X, Li B, Xiong F, et al
    Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin.
    Phytomedicine. 2021;86:153527.
    PubMed    
    Abstract available

  55. STAUDACHER HM, Nevin AN, Duff C, Kendall BJ, et al
    Epigastric symptom response to low FODMAP dietary advice compared with standard dietetic advice in individuals with functional dyspepsia.
    Neurogastroenterol Motil. 2021 Apr 12:e14148. doi: 10.1111/nmo.14148.
    PubMed    
    Abstract available

  56. WILDER-SMITH C, Lee SH, Olesen SS, Low JY, et al
    Fructose intolerance is not associated with malabsorption in patients with functional gastrointestinal disorders.
    Neurogastroenterol Motil. 2021 Apr 12:e14150. doi: 10.1111/nmo.14150.
    PubMed    
    Abstract available

  57. WANG XJ, Carlson P, Chedid V, Maselli DB, et al
    Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome.
    Clin Transl Gastroenterol. 2021;12:e00329.
    PubMed    
    Abstract available

  58. SCIAVILLA P, Strati F, Di Paola M, Modesto M, et al
    Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients.
    Appl Microbiol Biotechnol. 2021 Apr 10. pii: 10.1007/s00253-021-11264.
    PubMed    
    Abstract available

  59. BARBERIO B, Yiannakou Y, Houghton LA, Black CJ, et al
    Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-up Study.
    Clin Gastroenterol Hepatol. 2021 Apr 8. pii: S1542-3565(21)00445.
    PubMed    
    Abstract available

  60. KACHRU N, Holmes HM, Johnson ML, Chen H, et al
    Antimuscarinic use among older adults with dementia and overactive bladder: a medicare beneficiaries study.
    Curr Med Res Opin. 2021 Apr 23:1. doi: 10.1080/03007995.2021.1920899.
    PubMed    
    Abstract available

  61. MENG Q, Qin G, Yao SK, Fan GH, et al
    Differences in dietary habits of people with vs without irritable bowel syndrome and their association with symptom and psychological status: A pilot study.
    World J Clin Cases. 2021;9:2487-2502.
    PubMed    
    Abstract available

  62. CAO DY, Hu B, Xue Y, Hanson S, et al
    Differential activation of colonic afferents and dorsal horn neurons underlie stress-induced and comorbid visceral hypersensitivity in female rats.
    J Pain. 2021 Apr 19. pii: S1526-5900(21)00210.
    PubMed    
    Abstract available

  63. SINGH V, Singh M, Friesen CA
    Colonic mucosal eosinophilia in children without inflammatory bowel disease.
    Hum Pathol. 2021 Apr 19. pii: S0046-8177(21)00056.
    PubMed    
    Abstract available

  64. CHAO G, Wang Z, Zhang S
    Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome.
    J Inflamm Res. 2021;14:1427-1436.
    PubMed    
    Abstract available

  65. ALBAYRAK B, Susgun S, Kucukakkas O, Akbas F, et al
    [Investigating of Relation Between Fibromyalgia Syndrome and Intestinal Microbiota].
    Mikrobiyol Bul. 2021;55:146-160.
    PubMed    
    Abstract available

  66. BLACK CJ, Ford AC
    Irritable bowel syndrome: a spotlight on future research needs.
    Lancet Gastroenterol Hepatol. 2021 Apr 16. pii: S2468-1253(21)00131.
    PubMed    


  67. LI H, Chen Y, Hu Z, Yi Y, et al
    Comparison of acupuncture and pinaverium bromide in the treatment of irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Medicine (Baltimore). 2021;100:e25604.
    PubMed    
    Abstract available

  68. WANG Q, Charmchi Z, George IC
    Restrictive diet in a patient with irritable bowel syndrome leading to Wernicke encephalopathy.
    BMC Gastroenterol. 2021;21:179.
    PubMed    
    Abstract available

  69. SAILER M
    [Slow transit constipation].
    Chirurg. 2021 Apr 20. pii: 10.1007/s00104-021-01399.
    PubMed    
    Abstract available

  70. VALDEZ-PALOMARES F, Nambo-Venegas R, Uribe-Garcia J, Mendoza-Vargas A, et al
    Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet.
    Food Funct. 2021;12:3206-3218.
    PubMed    
    Abstract available

  71. RAMIREZ-AMILL R, Torres EA
    Prevalence of Irritable Bowel Syndrome among Medical Students of Puerto Rico.
    P R Health Sci J. 2021;40:38-44.
    PubMed    
    Abstract available

  72. BAALEMAN DF, Gupta S, Benninga MA, Bali N, et al
    The Use of Linaclotide in Children with Functional Constipation or Irritable Bowel Syndrome: A Retrospective Chart Review.
    Paediatr Drugs. 2021 Apr 20. pii: 10.1007/s40272-021-00444.
    PubMed    
    Abstract available

  73. STOEVA MK, Garcia-So J, Justice N, Myers J, et al
    Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease.
    Gut Microbes. 2021;13:1-28.
    PubMed    
    Abstract available

  74. TERES LB, Sanz IG, Campos CM, Quintana AG, et al
    Bowel obstruction secondary to transdiaphragmatic intercostal hernia.
    Gastroenterol Hepatol. 2021 Apr 16. pii: S0210-5705(21)00109.
    PubMed    
    Abstract available

  75. HUNT M, Miguez S, Dukas B, Onwude O, et al
    The Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-Management of Irritable Bowel Syndrome: a Cross-Over, Randomized Controlled Trial.
    JMIR Mhealth Uhealth. 2021 Apr 14. doi: 10.2196/26152.
    PubMed    
    Abstract available

  76. ROSTAMI K, Bold J, Ismail Ali J, Parr A, et al
    An algorithm for differentiating food antigen-related gastrointestinal symptoms.
    Gastroenterol Hepatol Bed Bench. 2021;14:8-16.
    PubMed    
    Abstract available

  77. ENCK P, Klosterhalfen S
    The Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases.
    Front Pharmacol. 2021;12:641436.
    PubMed    
    Abstract available

  78. SHAH ED
    Cost-Effective Treatments for Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2020;16:47-49.
    PubMed    


  79. BISCHOFF SC, Kaden-Volynets V, Filipe Rosa L, Guseva D, et al
    Regulation of the gut barrier by carbohydrates from diet - Underlying mechanisms and possible clinical implications.
    Int J Med Microbiol. 2021;311:151499.
    PubMed    
    Abstract available

  80. CASTRO J, Garcia-Caraballo S, Maddern J, Schober G, et al
    Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents.
    Pain. 2021 Apr 13. pii: 00006396-900000000-98054.
    PubMed    
    Abstract available

  81. CHEN Y, Chu F, Lin J, Su Z, et al
    The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies.
    J Ethnopharmacol. 2021;275:114119.
    PubMed    
    Abstract available

  82. MIDENFJORD I, Grinsvall C, Koj P, Carnerup I, et al
    Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease.
    Neurogastroenterol Motil. 2021 Apr 16:e14156. doi: 10.1111/nmo.14156.
    PubMed    
    Abstract available

  83. NAZARIAN A, Bishay K, Gholami R, Scaffidi MA, et al
    Factors Associated with Poor Quality of Life in a Canadian Cohort of Patients with Inflammatory Bowel Disease: A Cross-sectional Study.
    J Can Assoc Gastroenterol. 2020;4:91-96.
    PubMed    
    Abstract available

  84. BERENS S, Schaefert R, Ehrenthal JC, Baumeister D, et al
    Different Dimensions of Affective Processing in Patients With Irritable Bowel Syndrome: A Multi-Center Cross-Sectional Study.
    Front Psychol. 2021;12:625381.
    PubMed    
    Abstract available

  85. MORI H, Hayashi S, Mori S, Ikegami T, et al
    A case of systemic nickel allergy with diarrhea-predominant irritable bowel syndrome in which nickel intake restriction and administration of a probiotic formulation were effective.
    Allergol Int. 2021 Apr 11. pii: S1323-8930(21)00041.
    PubMed    


  86. NICKERSON AJ, Rottgen TS, Rajendran VM
    Activation of KCNQ (KV7) K(+) channels in enteric neurons inhibits epithelial Cl(-) secretion in mouse distal colon.
    Am J Physiol Cell Physiol. 2021 Apr 14. doi: 10.1152/ajpcell.00536.2020.
    PubMed    
    Abstract available

  87. MALANCHUK LM, Riabokon MO, Malanchuk AS, Riabokon SS, et al
    RELATIONSHIP BETWEEN PATHOLOGICAL MENSTRUAL SYMPTOMS AND THE DEVELOPMENT OF EXTRAGENITAL FORMS OF LOCAL INFLAMMATION.
    Wiad Lek. 2021;74:64-67.
    PubMed    
    Abstract available

  88. DYADYK OO, Snisarevskyi PP, Snisarevska TP
    MORPHOLOGICAL FEATURES OF CELLULAR INFILTRATION IN THE MUCOSA OF LARGE INTESTINE IN ULCERATIVE COLITIS AND IRRITABLE BOWEL SYNDROME.
    Wiad Lek. 2021;74:57-63.
    PubMed    
    Abstract available

  89. JOEHNKE MS, Jeske S, Ispiryan L, Zannini E, et al
    Nutritional and anti-nutritional properties of lentil (Lens culinaris) protein isolates prepared by pilot-scale processing.
    Food Chem X. 2021;9:100112.
    PubMed    
    Abstract available

  90. HADI YB, Khan AA, Naqvi SFZ, Khan S, et al
    Are We Overradiating Patients with Irritable Bowel Syndrome?
    Inflamm Intest Dis. 2021;6:32-37.
    PubMed    
    Abstract available

  91. QUENEHERVE L, Drui D, Blin J, Pere M, et al
    Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms.
    Sci Rep. 2021;11:8077.
    PubMed    
    Abstract available

  92. HALMOS EP
    Editorial: defining a microbial signature to predict non-response to a FODMAP diet-a step closer or is it?
    Aliment Pharmacol Ther. 2021;53:646-647.
    PubMed    


  93. CHUMPITAZI BP, Shulman RJ
    Editorial: defining a microbial signature to predict non-response to a low FODMAP diet-a step closer or is it? Authors' reply.
    Aliment Pharmacol Ther. 2021;53:648-649.
    PubMed    


  94. GOODOORY VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, et al
    Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2021 Apr 6. pii: 00000434-900000000-98826.
    PubMed    
    Abstract available

  95. SHAH ED, Brenner DM, Chen VL
    Baseline Predictors of Discontinuation of Prescription Drug Therapy for IBS-C: Cohort Analysis at an Integrated Healthcare System.
    Dig Dis Sci. 2021 Mar 29. pii: 10.1007/s10620-021-06963.
    PubMed    
    Abstract available

  96. TURSI A, Elisei W, Franceschi M, Picchio M, et al
    The prevalence of symptomatic uncomplicated diverticular disease could be lower than expected: a single-center colonoscopy-based cohort study.
    Eur J Gastroenterol Hepatol. 2021 Apr 16. pii: 00042737-900000000-97250.
    PubMed    
    Abstract available

  97. MULLIN GE, Chey WD, Crowe SE
    The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.
    Gastroenterology. 2020;159:20-25.
    PubMed    


  98. KHOSHBIN K, Khanna L, Maselli D, Atieh J, et al
    Development and Validation of Test for "Leaky Gut" Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00642.
    PubMed    
    Abstract available

  99. BOLTE LA, Vich Vila A, Imhann F, Collij V, et al
    Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome.
    Gut. 2021 Apr 2. pii: gutjnl-2020-322670. doi: 10.1136/gutjnl-2020-322670.
    PubMed    
    Abstract available

  100. KAMP KJ, Levy RL, Munson SA, Heitkemper MM, et al
    Impact of COVID-19 on Individuals With Irritable Bowel Syndrome and Comorbid Anxiety and/or Depression.
    J Clin Gastroenterol. 2021 Mar 12. doi: 10.1097/MCG.0000000000001515.
    PubMed    
    Abstract available

  101. CALDERON G, Patel C, Camilleri M, James-Stevenson T, et al
    Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2021 Mar 12. doi: 10.1097/MCG.0000000000001521.
    PubMed    
    Abstract available

  102. ZHANG W, Chen X, Wong KC
    Noninvasive early diagnosis of intestinal diseases based on artificial intelligence in genomics and microbiome.
    J Gastroenterol Hepatol. 2021;36:823-831.
    PubMed    
    Abstract available

  103. SARTER L, Heider J, Kirchner L, Schenkel S, et al
    Cognitive and emotional variables predicting treatment outcome of cognitive behavior therapies for patients with medically unexplained symptoms: A meta-analysis.
    J Psychosom Res. 2021 Apr 7:110486. doi: 10.1016/j.jpsychores.2021.110486.
    PubMed    
    Abstract available

  104. NARAYANAN SP, Anderson B, Bharucha AE
    Sex- and Gender-Related Differences in Common Functional Gastroenterologic Disorders.
    Mayo Clin Proc. 2021;96:1071-1089.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;